SeqLL (SQL) EBITDA

Price: $6.5991
Market Cap: $185.31M
Avg Volume: -
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Beta: 1.286
52W Range: $6.76-6.76
Website: SeqLL

What is SeqLL's EBITDA?

  • SeqLL's annual EBITDA is $-3.86M.
  • SeqLL's quarterly EBITDA is $-66.88M.

What is EBITDA?

EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is a measure of a company's overall financial performance and is used as an alternative to net income in some circumstances.

How is EBITDA calculated?

EBITDA is calculated using the following formula:

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Related Metrics

Other important metrics to assess SeqLL's financial health include:

  • EBITDA Ratio - measures the company's EBITDA as a percentage of its revenue:
    • Annual: -328320.48%
    • Quarterly: -63.92%
  • Growth EBITDA - measures the annual growth rate of the company's EBITDA:
    • Annual: -56.58%
    • Quarterly: -6004.95%
  • Growth EBITDA Ratio - measures the annual growth rate of the company's EBITDA ratio:
    • Annual: -6288.40%
    • Quarterly: 0.00%

These metrics provide insights into SeqLL's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual EBITDA

$-3.86M

Quarterly EBITDA

$-66.88M

SeqLL Historical EBITDA
Historical EBITDA Ratio (Annual)
Historical EBITDA Ratio (Quarterly)

SeqLL Historical EBITDA Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2022.

Year EBITDA Growth EBITDA EBITDA Ratio Growth EBITDA Ratio
2022 $-3.86M -56.58% -328320.48% -6288.40%
2021 $-2.47M -280.04% -5139.32% -300.35%
2020 $-649.40K 70.07% -1283.70% 5.06%
2019 $-2.17M -14.27% -1352.05% -454.75%
2018 $-1.90M -30.54% -243.72% -124.32%
2017 $-1.45M 0.00% -108.65% 0.00%